Etukudo, E. M.’s paper systematically discusses that sesquiterpenoids 22, 25, 29, and 30 all have acetylcholinesterase (Ache) inhibitory effects, which can repair neuronal degeneration and treat Alzheimer’s disease associated with decreased Ache levels, as well as treat myasthenia gravis [56,57]. This evidence concerns the gene ACHE and early-onset autosomal dominant Alzheimer disease.